Oncology Drugs - Growth & Revenue Opportunities by Top Key Players of Market [Roche Diagnostics, Novartis, Celgene Corporation, AstraZeneca, Johnson & Johnson, Merck & Co., Eli Lilly & Co., Amgen, Pfizer & GlaxoSmithKline]

Oncology Drugs Market is Expected to Reach $111.9 Billion, Globally, by 2020

Augmentation in the prevalence and incidence rate of various cancers, growing popularity of biological and targeted modalities, along with the patent expiration of major cancer drugs are expected to drive the growth of global oncology drugs market. However, high initial capital investment in new drug development, long-term side effects associated with chemotherapy, and high cost of advanced therapies (targeted and immunotherapies) would limit the growth of the market.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/121

Increase in adoption of combination therapies instead of traditional cytotoxic therapies is a major factor that contributes to the market growth. The combinational therapies which include targeted therapy and immunotherapy (Biologic therapy), is expected to witness ~10% surge in its market share collectively by 2020.

The global oncology drugs market is experiencing a shift in therapeutic modalities i.e. from traditional cytotoxic agents to newly develop targeted and immunotherapeutic modalities. Tumor cell specificity, an attribute of aforementioned modality, has reduced drug remission rates and has rendered an enhanced rate of survival in cancer patients thus, complementing the market growth. However, chemotherapeutic modalities would continue to be the leading therapeutic modality segment owing to its higher adoption rate and economic pricing. Going forward, the demand for the chemotherapy modality might confront a negative influence due to marginal efficacy and chronic side effects such as anemia.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/121

Geographically, the developed economies such as North America and Europe collectively accounted for ~65% of market share in 2014, due to higher adoption rates and advanced hospital settings. However, developing economies are expected to experience potential opportunities owing to the emergence of biosimilars in monoclonal antibodies, and improved medical infrastructure.

A majority of the oncology drug manufacturers have adopted collaboration and acquisition as key developmental strategies to achieve a competitive edge. Moreover, companies are also forming strategic alliances to accelerate the process of clinical trials. These strategies have proved to be effective in helping key market players retain their leading positions in the global oncology drugs market. Key companies profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson & Johnson, Merck & Co., Eli Lilly & Co., Amgen Inc., Pfizer and GlaxoSmithKline.

Key Findings of Oncology Drugs Market:

- Immunotherapy/biological drugs segment expected to grow at a double digit CAGR during the forecast period and would grow at the fastest rate

- Blood cancer is the major revenue generating segment in the global oncology drug application market however, lung cancer segment is expected to grow fastest among all

- Currently, North America garners a major share in the oncology drugs market, in terms of market size

- Asia Pacific oncology drug market is dominated by China and Japan, together contributing to ~60% of the regional market revenue in 2014

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/121

Table Of Content

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segment
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 Market beyond what to expect by 2025

2.1.1 Moderate growth scenario
2.1.2 Rapid growth scenario
2.1.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Development of novel immuno-oncology drug products
3.3 Key findings

3.3.1 Top Factors impacting oncology drugs market
3.3.2 Top investment pockets of oncology drugs market
3.3.3 Top winning strategies of oncology drugs market

3.4 Porters five forces analysis

3.4.1 Bargaining power of buyers (low)
3.4.2 Bargaining power of suppliers (moderate)
3.4.3 Threat of new entrants (Low)
3.4.4 Threat of substitutes (moderate)
3.4.5 Intense competitive rivalry

3.5 Value chain analysis

3.5.1 Primary activities
3.5.2 Support activities

3.6 Government regulations and reimbursement

3.6.1 Regulations in United States
3.6.2 Regulations in Europe
3.6.3 Regulations in Asia-Pacific
3.6.4 Reimbursement scenario

3.7 Patent analysis

3.7.1 Patent Analysis by type of patents
3.7.2 Patent analysis by geography

3.8 Market share analysis, 2013
3.9 Clinical trials for oncology drugs
3.10 Market dynamics

3.10.1 Drivers

3.10.1.1 Rising incidence and prevalence of various cancer types
3.10.1.2 Growing importance of biological and targeted drug therapies
3.10.1.3 Expiration of key patents and biosimilars impact
3.10.1.4 Acquisitions and collaborations bolt-on strategies driving the market growth

3.10.2 Restraints

3.10.2.1 High cost of drug development and threat of failure
3.10.2.2 Adverse effects of anti-cancer drug therapy

3.10.3 Opportunities

3.10.3.1 Advancement of anti-cancer drugs research
3.10.3.2 Personalized medicine approach

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/global-oncology-drugs-market-is-expected-to-reach-111-9-billion-by-2020-allied-market-research.html

About Us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.